CTLA4 and graft versus host disease: In a xenogeneic model with NSG mice, treatment with CTLA-4 immunoglobulin to block T cell co-stimulation was shown to impede GvHD development and spleens isolated from mice had reduced gene expression of Th17 differentiation (44), which agrees with our findings presented here.